Abbott Acquires Exact Sciences to Enter Cancer Diagnostics Market
In November, Abbott (ABT) announced an agreement to acquire Exact Sciences (EXAS), a move that will position the company to enter and lead in the fast-growing cancer diagnostics market. Abbott continues to expect the transaction to close in the second quarter of 2026.
